Miller VA - Search Results

1

Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.

Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE. Herbst RS, et al. Among authors: miller va. Clin Cancer Res. 2007 Oct 15;13(20):6175-81. doi: 10.1158/1078-0432.CCR-07-0460. Clin Cancer Res. 2007. PMID: 17947484 Clinical Trial.

2

Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.

Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Miller VA, et al. Am J Clin Oncol. 1995 Aug;18(4):303-6. doi: 10.1097/00000421-199508000-00007. Am J Clin Oncol. 1995. PMID: 7625371 Clinical Trial.

3

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

4

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.

Miller VA, Ng KK, Grant SC, Kindler H, Pizzo B, Heelan RT, von Roemeling R, Kris MG. Miller VA, et al. Ann Oncol. 1997 Dec;8(12):1269-71. doi: 10.1023/a:1008219125746. Ann Oncol. 1997. PMID: 9496394 Free article. Clinical Trial.

5

Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer.

Kindler HL, Kris MG, Smith IE, Miller VA, Grant SC, Krebs JB, Ross GA, Slevin ML. Kindler HL, et al. Among authors: miller va. Am J Clin Oncol. 1998 Oct;21(5):438-41. doi: 10.1097/00000421-199810000-00003. Am J Clin Oncol. 1998. PMID: 9781595 Clinical Trial.

6

Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.

Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, Gill GM, Loewen GR, Truglia JA, Ulm EH, Warrell RP Jr. Miller VA, et al. Clin Cancer Res. 1996 Mar;2(3):471-5. Clin Cancer Res. 1996. PMID: 9816192 Clinical Trial.

7

Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.

Dickler MN, Ragupathi G, Liu NX, Musselli C, Martino DJ, Miller VA, Kris MG, Brezicka FT, Livingston PO, Grant SC. Dickler MN, et al. Among authors: miller va. Clin Cancer Res. 1999 Oct;5(10):2773-9. Clin Cancer Res. 1999. PMID: 10537341

8

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma.

Miller VA, Ng KK, Krug LM, Perez W, Pizzo B, Heelan RT, Kris MG. Miller VA, et al. Cancer. 2000 Mar 1;88(5):1045-50. doi: 10.1002/(sici)1097-0142(20000301)88:5<1045::aid-cncr14>3.0.co;2-j. Cancer. 2000. PMID: 10699893 Clinical Trial.

9

Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.

Miller VA, Krug LM, Ng KK, Pizzo B, Perez W, Heelan RT, Kris MG. Miller VA, et al. J Clin Oncol. 2000 Mar;18(6):1346-50. doi: 10.1200/JCO.2000.18.6.1346. J Clin Oncol. 2000. PMID: 10715307 Clinical Trial.

10

Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.

Miller VA, Kris MG. Miller VA, et al. Semin Oncol. 2000 Apr;27(2 Suppl 3):3-10. Semin Oncol. 2000. PMID: 10810932 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters